Zhang study [47] revealed increased MyD88 mRNA expression in HBV-transgenic mice having non-alcoholic fatty liver disease as well as in HepG2.2.15 cells treated with stearic acid to induce steatosis. This evidence concerns the gene MYD88 and alcoholic fatty liver disease.